Canadian Plastics

Avient adding capacity for medical-grade Mevopur materials in Asia-Pacific

Canadian Plastics   


The material supplier is equipping an existing facility in Singapore with a new production line to meet growing demand for the specialty polymers in that region.

Photo Credit: Avient Corp.

U.S.-based specialty material supplier Avient Corp. is equipping an existing facility in Singapore with a new production line to meet the growing demand for specialty pre-coloured, medical grade Mevopur polymers in the region.

The new line will be installed at the EN-ISO13485-2016 certified site, and complements similar capabilities in North America and Europe.

“When our newly added production line is validated and goes on-stream in Singapore next quarter, Avient will be able to increase its capacity to supply these materials, which address the particular needs of the healthcare industry in the Asia-Pacific region,” said Say-Eng Lee, vice president and general manager, colour and additives, Asia. “This allows our customers the choice of a masterbatch concentrate or pre-coloured material that best fits their production process”.

According to Avient, demand from local and regional customers for pre-coloured Mevopur materials stems from an increase in the Asia Pacific market for medical and diagnostic devices and pharmaceutical packaging. “As part of a global network of ISO13485 sites established starting in 2010, the Singapore facility also plays an important role in supporting product development globally,” Avient officials said in a statement.


Avon Lake, Ohio-based Avient was formerly known as PolyOne Corp., and is one of North America’s largest compounder and concentrate makers and as one of the region’s largest resin distributors.


Stories continue below

Print this page

Related Stories